Eosinophil-mediated inflammation in the absence of eosinophilia-Reference-Cited by-同舟云学术

Eosinophil-mediated inflammation in the absence of eosinophilia

Published:2021 Issue:3 Volume:11 Page:
ISSN:2233-8276
Container-title:Asia Pacific Allergy
language:en
Short-container-title:Asia Pac Allergy

Author:

Miyabe Yui¹^ORCID,Kobayashi Yoshiki²³^ORCID,Fukuchi Mineyo¹^ORCID,Saga Akiko¹^ORCID,Moritoki Yuki¹^ORCID,Saga Tomoo¹,Akuthota Praveen⁴^ORCID,Ueki Shigeharu¹^ORCID

Affiliation:

1. Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.

2. Airway Disease Section, Department of Otorhinolaryngology, Kansai Medical University, Hirakata, Japan.

3. Allergy Center, Kansai Medical University, Hirakata, Japan.

4. Division of Pulmonary, Critical Care, and Sleep Medicine, University of California, San Diego, La Jolla, CA, USA.

Publisher

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology

Subject

Dermatology,Immunology and Allergy

Link

https://apallergy.org/pdf/10.5415/apallergy.2021.11.e30

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choosing the right biologic treatment for individual patients with severe asthma – Lessons learnt from Picasso;Respiratory Medicine;2024-11

2. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma;Journal of Allergy and Clinical Immunology;2024-09

3. Eosinophilic mucus diseases;Allergology International;2024-07

4. Exploring the role of eosinophil cationic protein (ECP) in schizophrenia: Insights and implications;Medicine;2024-05-31

5. IBUPROFEN INJECTABLE MICROEMULSION PREPARATION COATED BY CHITOSAN: FORMULATION, CHARACTERIZATION, IN VITRO PERFORMANCE, ANTI-INFLAMMATION ACTIVITY, AND HEMATOLOGY ASSESSMENT;International Journal of Applied Pharmaceutics;2024-05-07